Spanish medtech company QUIBIM has closed €8 million in new seed round co-led by Amadeus Capital Partners and Adara Ventures. Other participants are-Crista Galli Ventures, Apex Ventures, Partech Ventures and existing shareholders, including Tech Transfer UPV, managed by Clave Capital and Juan Roig.
Partner at Adara Ventures, Rocio Pillado said “QUIBIM’s rapid adoption is an indicator of how innovative doctors and researchers are eager to have access to and exploit AI technology and methods that can automatically recognise complex patterns in imaging data, to get quantitative assessments and improve the service they provide.”
About Company
Established in 2012, QUIBIM helps hospitals and pharmaceutical companies detect diseases early and systematically by its specialization in ‘radiomics’ technology, QUIBIM Precision. This tool extracts and quantifies disease-specific biomarkers from medical images with ultra-high accuracy. The company has already launched 20+ algorithms for a range of conditions including liver disease, Alzheimer’s, cancer and osteoarthritis. Its products are used in over 70 hospitals and 11 clinical trials across the world, with 600,000 analyses and 6.5 million images processed to date.
Most notably, the startup recently launched CT Scan and chest X-ray products for COVID-19. Co-founders Dr. Ángel Alberich-Bayarri and Prof. Luis Marti-Bonmati had already established the process for the development of biomarkers, which was adopted in 2013 by the ESR (European Society of Radiology) as the official industry standard.
They again set a benchmark in March 2020 when QUIBIM became a main AI platform for screening for COVID-19 across Europe. Shortly after, the RSNA (Radiological Society of North America), with more than 52,000 members from 153 countries, joined the initiative with the goal of creating a global medical repository of COVID-19 cases, with the European arm running on QUIBIM Precision.
By incorporating AI technologies, QUIBIM also improves the performance and workflow of radiology departments. The company is launching its qp-Suites product family, designed to support radiologists by centralising the essential tools for clinical diagnosis in one platform, increasing operational efficiency.
